Roger Trotter, MD
Emergency Medicine · Dodge City, KSNPI 1548225121
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 375 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 20.5% — the pattern of someone who eats at a lot of different presentations. Among emergency medicine clinicians in KS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 375 payments — averaging $15.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- Novo Nordisk$1K
- Lilly USA, LLC$641
- AbbVie$438
- Pfizer$266
- Johnson & Johnson$247
- plus $2K from 25 others
What the payments were for
- Food & beverage$5,672100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 48 | $1,162 |
| Novo Nordisk | 89 | $1,109 |
| Lilly USA, LLC | 49 | $641 |
| AbbVie(2 entities) | 30 | $438 |
| Pfizer | 19 | $266 |
| Johnson & Johnson | 20 | $247 |
| Abbott | 15 | $215 |
| Merck | 13 | $184 |
| Sunovion Pharmaceuticals Inc. | 14 | $170 |
| Electromed, Inc. | 10 | $170 |
| Sumitomo Pharma America, Inc. | 9 | $142 |
| Novartis | 7 | $112 |
| Amgen | 7 | $101 |
| Sanofi-aventis U.S. LLC | 6 | $91 |
| Bayer | 6 | $82 |
| GSK | 4 | $65 |
| Dexcom, Inc. | 3 | $60 |
| Exact Sciences | 4 | $58 |
| Amarin Pharma, Inc. | 2 | $46 |
| Eisai Inc. | 3 | $45 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| Sanofi Pasteur Inc. | 2 | $36 |
| Boehringer Ingelheim | 2 | $35 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $26 |
| Seqirus USA Inc | 1 | $20 |
| Medtronic | 1 | $18 |
| Mylan Specialty L.p. | 1 | $13 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$352
- AIRSUPRA$229
- BREZTRI$229
- BREZTRI AEROSPHERE$124
- SYMBICORT$124
How this compares
$5,672 in reported general payments places this provider in the 95th percentile of 334 emergency medicine providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 70 | $58,297 |
| EliquisApixaban | 140 | $56,792 |
| JardianceEmpagliflozin | 86 | $55,731 |
| FarxigaDapagliflozin Propanediol | 58 | $46,997 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 90 | $44,067 |
| JanuviaSitagliptin Phosphate | 55 | $43,070 |
| TrulicityDulaglutide | 27 | $33,239 |
| RybelsusSemaglutide | 27 | $29,458 |
| AptiomEslicarbazepine Acetate | 23 | $28,754 |
| EntrestoSacubitril/Valsartan | 53 | $25,704 |
| OxycontinOxycodone Hcl | 13 | $16,716 |
| MyrbetriqMirabegron | 12 | $13,481 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 39 | $12,020 |
| RytaryCarbidopa/Levodopa | 11 | $10,164 |
| SymbicortBudesonide/Formoterol Fumarate | 31 | $8,963 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Combivent Respimat | $35 | $99,798176 claims |
| AstraZenecaFarxiga, Symbicort, Brilinta | $1,162 | $60,463100 claims |
| Johnson & JohnsonXarelto | $247 | $58,29770 claims |
| PfizerEliquis | $266 | $56,792140 claims |
| MerckJanuvia | $184 | $43,07055 claims |
| Lilly USA, LLCTrulicity, Olanzapine | $641 | $35,07639 claims |
| Novo NordiskRybelsus | $1,109 | $29,45827 claims |
| Sunovion Pharmaceuticals Inc.Aptiom | $170 | $28,75423 claims |
| NovartisEntresto | $112 | $25,70453 claims |
| GSKArexvy, Anoro Ellipta, Shingrix | $65 | $22,29070 claims |
| AbbVieLinzess | $438 | $8,88618 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $142 | $6,30325 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 334 emergency medicine providers in Kansas.
Other emergency medicine in Dodge City
- Merrill ConantDodge City$1K
- Joseph WaeckerleOverland Park$266K
- Nima SaraniKansas City$65K
- Nicholas HoseyKansas City$56K
- Chad CannonKansas City$23K
- Andrew PirotteKansas City$2K
- Thomas KreamerOverland Park$2K
- Nathan SmithHays$1K
- Martha FanningOverland Park$1K
- Bradley JacksonKansas City$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.